Trial: 201806093

Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma

Phase

II

Principal Investigator

Huang, Jiayi

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov